Publisher
Springer International Publishing
Reference23 articles.
1. Kobayashi T, Nakayama R, Takatani O, Kimura K. Positive chronotropic and inotropic actions of new antitumor agent adriamycin and its cardiotoxicity–its special references to myocardial contractile force and the change of the transmembrane action potential. Jpn Circ J. 1972;36:259–65.
2. Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 1973;32:302–14.
3. Rinehart JJ, Lewis RP, Balcerzak SP. Adriamycin cardiotoxicity in man. Ann Intern Med. 1974;81:475–8.
4. Greco FA, Brereton HD, Rodbard D. Noninvasive monitoring of adriamycin cardiotoxicity by “Sphygmo-Recording” of the pulse wave delay (QKd interval). Cancer Treat Rep. 1976;60:1239–45.
5. Ramos A, Meyer RA, Korfhagen J, Wong KY, Kaplan S. Echocardiographic evaluation of adriamycin cardiotoxicity in children. Cancer Treat Rep. 1976;60:1281–4.